Aurobindo Pharma announced that Medicines Control Council (MCC) South Africa has granted approval to manufacture and market 2 more products in South Africa, namely, `Auro-Amplicillin` 500 mg and 100 mg in an injection form with an active ingredient `Ampicillin Sodium` in the anti-infective category and `Auropidone` 0.5 mg in a tablet form with an active ingredient `Risperidone` in the CNS category.
Aurobindo now has a total of 37 products approved by MCC.
No comments:
Post a Comment